Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - ALNYLAM PHARMACEUTICALS, INC. | d835246d10k.htm |
| EX-12 - EX-12 - ALNYLAM PHARMACEUTICALS, INC. | d835246dex12.htm |
| EXCEL - IDEA: XBRL DOCUMENT - ALNYLAM PHARMACEUTICALS, INC. | Financial_Report.xls |
| EX-23.1 - EX-23.1 - ALNYLAM PHARMACEUTICALS, INC. | d835246dex231.htm |
| EX-32.1 - EX-32.1 - ALNYLAM PHARMACEUTICALS, INC. | d835246dex321.htm |
| EX-32.2 - EX-32.2 - ALNYLAM PHARMACEUTICALS, INC. | d835246dex322.htm |
| EX-31.2 - EX-31.2 - ALNYLAM PHARMACEUTICALS, INC. | d835246dex312.htm |
| EX-31.1 - EX-31.1 - ALNYLAM PHARMACEUTICALS, INC. | d835246dex311.htm |
EXHIBIT 21.1
SUBSIDIARIES OF THE REGISTRANT
| Name |
Ownership Percentage |
Jurisdiction of Organization | ||
| Alnylam U.S., Inc. |
100% | Delaware | ||
| Alnylam Europe AG |
100% | Germany | ||
| Alnylam Securities Corporation |
100% | Massachusetts | ||
| Alnylam (Bermuda) Ltd. |
100% | Bermuda | ||
| Alnylam UK Limited |
100% | United Kingdom | ||
| Sirna Therapeutics, Inc. |
100% | Delaware |